Voluntis was founded in 2001 by three entrepreneurs who believed that innovative medical solutions built with advanced information technologies would transform patient lives, enhance medical practices and quality of care by improving medical real-life outcomes and thus increase healthcare system efficiency.
Every day, Voluntis teams seek to invent secure, collaborative and patient-centric digital health solutions with a unique combination of web and mobile development excellence, medical and regulatory expertise and certified quality-orientated processes. With more than 600,000 patients managed and more than 50 programs deployed, our track-record speaks for itself.
At Voluntis, we are all guided by clear and simple values:
- We are focused on patients: we are committed to change the daily lives of patients by addressing their unmet needs and by empowering them to manage their chronic condition.
- We are passionate about innovation: we design next-generation solutions that combine digital and medical expertise to solve the daily problems of patients and care givers.
- We work with respect and integrity: everyday, we take care of the people we touch, our patients, customers, partners and employees.
- We are driven by excellence: in everything we do, we behave ethically and we strive to attain the highest level of quality. Always working to enhance our processes, Voluntis is certified ISO 9001, ISO 13485 and compliant with ISO 14971 standard. Our design methodologies embed the harmonized IEC 62304 and IEC 62366 standards.
Chief Executive Officer, President of the Management Board and Founder
Chief Operations Officer, Co-Founder and Member of the Management Board
Geneviève D'ORSAY, MD
Chief Strategy & Marketing Officer and Member of the Management Board
Vice-President Innovation and Co-Founder.
Vice-President Consulting, Infrastructure & Support
Vice-President Quality Assurance & Validation
Formed by the law of 31 December 2012, Bpifrance (a public sector investment bank) is the outcome of the merger between OSEO, the FSI, CDC Entreprises and FSI Régions. Its two shareholders are the French state and the Caisse des Dépôts bank. Its object is to support businesses (SMEs, medium-sized enterprises and larger companies of a strategic importance to the French economy), from start-up through to stock market flotation, by providing loans, guarantees and equity. Bpifrance also provides enhanced support and backing for innovation, export, and external growth. With its 42 regional offices, it is a one-stop shop for entrepreneurs in each region for all their finance and investment needs. www.bpifrance.fr - Follow us on Twitter: @bpifrance
Founded in 1996, Innovation Capital is an international venture capital firm based in Paris with a local presence in the Silicon Valley. With over €450 million under management, Innovation Capital current focus is on venture and growth investments in the Innovative Healthcare Services space in Europe. Innovation Capital aims to create value by providing talented entrepreneurs with the resources, experience, and network necessary to turn innovative technologies into great businesses.
Vesalius Biocapital is a pan-european venture capital group investing in early stage innovative biotech companies. Most of our investments consist of therapeutic companies, developing new drugs and devices. Our total fund size is €160 million. The team is composed of experienced life science experts and business people.
Qualcomm Incorporated is a world leader in 3G, 4G and next-generation wireless technologies. Qualcomm Incorporated includes Qualcomm’s licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a wholly-owned subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm’s engineering, research and development functions, and substantially all of its products and services businesses, including its semiconductor business, QCT. For more than 25 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information, entertainment and each other. For more information, visit Qualcomm’s website, OnQ blog, Twitter and Facebook pages.
CM-CIC Capital Innovation
CM-CIC Capital Innovation specializes in venture capital tech investments. In addition to Sudinnova, it supports the development of companies with strong growth potential in dynamic sectors such as information technologies, healthcare, industrial innovation and the environment. CM-CIC Capital Innovation is a subsidiary of CM-CIC Capital Finance, the investment wing and merchant bank of the Crédit Mutuel-CIC Group. With €2.6 billion in capital (including €1.9 billion in equity), a portfolio of 630 companies, and 6 regional branches throughout France (Paris, Lyon, Nantes, Lille, Strasbourg and Bordeaux), CM-CIC Capital Finance is one of the few merchant banks that invests its own funds for the long term.
CapDecisif Management manages CapDecisif, FCPR CapDecisif 3 and G1J Ile-De-France, early-stage venture capital funds sponsored by Bpifrance, the Ile-de-France region and BNP. Since 2002, the management team has invested in 32 new information technology companies in software, the life sciences, biotech, energy and the environment, and the engineering sciences. CapDecisif Management currently manages almost €100 million.
Created in 1927, Sham is a mutual insurance company specializing in risk management for healthcare, social and medico-social stakeholders. It is the leading insurer for medical legal liability in France, with an asset portfolio of €1.6 billion invested in various channels. Since 2007, the company has also been investing in innovative healthcare businesses.